Prime Medicine, Inc. (PRME)
3.70
-0.01
(-0.27%)
USD |
NASDAQ |
Sep 04, 16:00
3.695
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine SG&A Expense (TTM) : 54.39M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.39M |
| March 31, 2026 | 56.47M |
| December 31, 2025 | 52.35M |
| September 30, 2025 | 49.91M |
| June 30, 2025 | 52.80M |
| March 31, 2025 | 52.29M |
| December 31, 2024 | 50.16M |
| September 30, 2024 | 50.94M |
| June 30, 2024 | 47.34M |
| March 31, 2024 | 45.39M |
| December 31, 2023 | 43.39M |
| September 30, 2023 | 39.93M |
| Date | Value |
|---|---|
| June 30, 2023 | 36.04M |
| March 31, 2023 | 32.75M |
| December 31, 2022 | 29.82M |
| September 30, 2022 | 27.38M |
| June 30, 2022 | 23.80M |
| March 31, 2022 | 18.76M |
| December 31, 2021 | 13.92M |
| September 30, 2021 | 8.075M |
| June 30, 2021 | 5.048M |
| March 31, 2021 | 2.727M |
| December 31, 2020 | 1.338M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Beam Therapeutics, Inc. | 125.40M |
| Twist Bioscience Corp. | 290.29M |
| Sana Biotechnology, Inc. | 44.71M |
| Intellia Therapeutics, Inc. | 136.25M |
| Revolution Medicines, Inc. | 330.91M |